| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Biotechnology (IBB) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Biotechnology sector is negative (overall -2.1, positive 2, negative -4) on 20251104. The forces of Market Risk Prefrence (-1.5), Valuation Sentiment (-1), Sector Price Trend (-0.8), and Broad Market Trend (-0.7) will drive down the price. The forces of Price Level (0), Option Speculation (0.75), and Sentiment towards Fundamentals (1.2) will drive up the price. The swing to downside will be significant considering the negative sentiment forces (-4). The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on IBB trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Market Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 0% | 0.3% | 156.08 | 63 | -0.88% | 0% | -0.8 | -2.1 | 1.2 | 7 |
| 2025-11-03 | 1% | 0.3% | 157.46 | 78 | -1.2% | 0.06% | 0.2 | -0.7 | 1.8 | 4.8 |
| 2025-11-02 | 0% | 0.3% | 1 | 2.8 | 2 | 0 | ||||
| 2025-11-01 | 0% | 0.4% | 1 | 2.8 | 2 | 0 | ||||
| 2025-10-31 | 1% | 0.4% | 159.38 | 98 | 1.32% | 0.38% | 1 | 2.8 | 2 | 4.5 |
| 2025-10-30 | 0% | 0.3% | 157.31 | 86 | 0.22% | 0.19% | 0.5 | 1.5 | 1.7 | 1 |
| 2025-10-29 | 0% | 0.3% | 156.97 | 86 | -0.44% | 0.26% | 0.7 | 3.8 | 1.9 | 0 |
| 2025-10-28 | 0% | 0.3% | 157.66 | 96 | 0.35% | 0.39% | 0.6 | 1.9 | 0.6 | 7.7 |
| 2025-10-27 | 1% | 0.3% | 157.11 | 90 | 1.26% | 0.45% | 1.6 | 1.6 | -0.5 | 4 |
| 2025-10-26 | 1% | 0.1% | 0.4 | -0 | 0 | 7 | ||||
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| IBB Behaviors |
| ● Biotechnology (IBB) (-22%) is likely to move marginally lower. When the price move is against the technical setup, sentiment and emotion, it's a sign of trend reversal. |
| 1 (7) Metsera Deems Novo Nordisk's $10 Bln Offer Superior To Pfizer's Revised Bid Metsera, Inc. (MTSR), a biotechnology company, Tuesday announced that the revised acquisition proposal received from pharmaceutical major Novo Nordisk A/S (NVO) is superior to Pfizer's revised bid. (https://www.rttnews.com/) Tue. Nov 4, 2025 | |
| 2 (7) Are Biotech ETFs Poised for a Surge? This Stock May Hold the Key Biotech ETFs could play an intriguing role to end the year and start 2026, with one stock capturing the category's potential and performance. (https://www.etftrends.com/) Mon. Nov 3, 2025 | |
| 3 (7) Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call (https://www.benzinga.com/) Mon. Nov 3, 2025 | |
| 4 (-2) Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market. (https://www.cnbc.com/) Mon. Nov 3, 2025 | |
| 5 (7) Opinion: Biotech is back. Here’s why these rallying stocks belong in your portfolio now. The volatile sector is seeing greater stability, and these four stocks can profit. (https://www.marketwatch.com/) Mon. Nov 3, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA